GO42784 Study
lidERA (Main Study) · ABEMA (Sub Study)
Study Information
Disease State
ER+, HER2-Breast Cancer
Principal Investigator
Myron Bednar, MD
Phase III
Enrollment is currently closed. Active patients are continuing treatment and follow-up care.
Contact HHO
All questions and feedback are welcome, anytime.
Menu
Subscribe
Sign up for the HHO newsletter to stay up to date on the latest news within the practice and the community.